Loading…
avatar for Solomon Iyasu

Solomon Iyasu

Merck & Co., Inc.
Vice President and Head of Pharmacoepidemiology
Dr. Iyasu joined Merck and Co. in August of 2015 as head of Pharmacoepidemiology in the Center for Observational and Real-World Evidence (CORE). In his current role, he leads a department that is responsible for designing and conducting postapproval observational safety and effectiveness studies (PASS/PAERs), real-world data analytics to characterize disease epidemiology, inform early development, clinical trial design and endpoint strategy (selection, validation of PROs and clinical outcomes, biomarkers).

My Speakers Sessions

Wednesday, June 26
 

10:30am